{"id":"https://openalex.org/W4200330587","doi":"https://doi.org/10.1111/bcp.15150","title":"Incidence and nature of adverse drug events in paediatric intensive care units: A prospective multicentre study","display_name":"Incidence and nature of adverse drug events in paediatric intensive care units: A prospective multicentre study","publication_year":2021,"publication_date":"2021-12-08","ids":{"openalex":"https://openalex.org/W4200330587","doi":"https://doi.org/10.1111/bcp.15150","pmid":"https://pubmed.ncbi.nlm.nih.gov/34878686"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.15150","doi":"https://doi.org/10.1111/bcp.15150","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.15150","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15150","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15150","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049968381","display_name":"Anwar A. Alghamdi","orcid":"https://orcid.org/0000-0001-8474-2543","observed_orcids":["https://orcid.org/0000-0001-8474-2543"]},"institutions":[{"id":"https://openalex.org/I185163786","display_name":"King Abdulaziz University","ror":"https://ror.org/02ma4wv74","country_code":"SA","type":"education","lineage":["https://openalex.org/I185163786"]},{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB","SA"],"is_corresponding":true,"raw_author_name":"Anwar A. Alghamdi","raw_affiliation_strings":["Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester  UK","Health Information Technology Department, Faculty of Applied Studies King Abdul Aziz University  Jeddah Kingdom of Saudi Arabia","Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester UK; Health Information Technology Department, Faculty of Applied Studies King Abdul Aziz University Jeddah Kingdom of Saudi Arabia"],"raw_orcid":"https://orcid.org/0000-0001-8474-2543","affiliations":[{"raw_affiliation_string":"Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester  UK","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311"]},{"raw_affiliation_string":"Health Information Technology Department, Faculty of Applied Studies King Abdul Aziz University  Jeddah Kingdom of Saudi Arabia","institution_ids":["https://openalex.org/I185163786"]},{"raw_affiliation_string":"Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester UK; Health Information Technology Department, Faculty of Applied Studies King Abdul Aziz University Jeddah Kingdom of Saudi Arabia","institution_ids":["https://openalex.org/I185163786","https://openalex.org/I2799725268","https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056832225","display_name":"Richard Neil Keers","orcid":"https://orcid.org/0000-0001-7854-8154","observed_orcids":["https://orcid.org/0000-0001-7854-8154"]},"institutions":[{"id":"https://openalex.org/I15704514","display_name":"Greater Manchester Mental Health NHS Foundation Trust","ror":"https://ror.org/05sb89p83","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I15704514"]},{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Richard N. Keers","raw_affiliation_strings":["Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester  UK","Medicines Management Team, Greater Manchester Mental Health NHS Foundation Trust, Prestwich  Manchester UK","Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester UK; Medicines Management Team, Greater Manchester Mental Health NHS Foundation Trust, Prestwich Manchester UK"],"raw_orcid":"https://orcid.org/0000-0001-7854-8154","affiliations":[{"raw_affiliation_string":"Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester  UK","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311"]},{"raw_affiliation_string":"Medicines Management Team, Greater Manchester Mental Health NHS Foundation Trust, Prestwich  Manchester UK","institution_ids":["https://openalex.org/I15704514"]},{"raw_affiliation_string":"Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester UK; Medicines Management Team, Greater Manchester Mental Health NHS Foundation Trust, Prestwich Manchester UK","institution_ids":["https://openalex.org/I15704514","https://openalex.org/I2799725268","https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010715227","display_name":"Adam B. Sutherland","orcid":"https://orcid.org/0000-0002-5198-3727","observed_orcids":["https://orcid.org/0000-0002-5198-3727"]},"institutions":[{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210160221","display_name":"Royal Manchester Children's Hospital","ror":"https://ror.org/052vjje65","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210160221"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adam Sutherland","raw_affiliation_strings":["Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester  UK","Pharmacy Department Royal Manchester Children's Hospital  Manchester UK","Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester UK; Pharmacy Department Royal Manchester Children's Hospital Manchester UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester  UK","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311"]},{"raw_affiliation_string":"Pharmacy Department Royal Manchester Children's Hospital  Manchester UK","institution_ids":["https://openalex.org/I4210160221"]},{"raw_affiliation_string":"Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester UK; Pharmacy Department Royal Manchester Children's Hospital Manchester UK","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311","https://openalex.org/I4210160221"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016262146","display_name":"Mark Hann","orcid":"https://orcid.org/0000-0002-4508-5584","observed_orcids":["https://orcid.org/0000-0002-4508-5584","https://orcid.org/0000-0003-4481-4068"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Hann","raw_affiliation_strings":["Biostatistics Group at University of Manchester Manchester UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistics Group at University of Manchester Manchester UK","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jennifer Gray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800789647","display_name":"University Hospitals Bristol NHS Foundation Trust","ror":"https://ror.org/04nm1cv11","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800789647","https://openalex.org/I4392738148","https://openalex.org/I4405276282"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jennifer Gray","raw_affiliation_strings":["Pharmacy Department University Hospitals Bristol NHS Foundation Trust Bristol UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department University Hospitals Bristol NHS Foundation Trust Bristol UK","institution_ids":["https://openalex.org/I2800789647"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Graham Mason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160221","display_name":"Royal Manchester Children's Hospital","ror":"https://ror.org/052vjje65","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210160221"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Graham Mason","raw_affiliation_strings":["Paediatric Critical Care Royal Manchester Children's Hospital Manchester UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Paediatric Critical Care Royal Manchester Children's Hospital Manchester UK","institution_ids":["https://openalex.org/I4210160221"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114080084","display_name":"Rhian E. Isaac","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155225","display_name":"Birmingham Women\u2019s and Children\u2019s NHS Foundation Trust","ror":"https://ror.org/056ajev02","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210155225"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rhian E. Isaac","raw_affiliation_strings":["Pharmacy Department Birmingham Women and Children's NHS Foundation Trust Birmingham UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Department Birmingham Women and Children's NHS Foundation Trust Birmingham UK","institution_ids":["https://openalex.org/I4210155225"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005808294","display_name":"Darren Mark Ashcroft","orcid":"https://orcid.org/0000-0002-2958-915X","observed_orcids":["https://orcid.org/0000-0002-2958-915X"]},"institutions":[{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4392738208","display_name":"NIHR Greater Manchester Patient Safety Translational Research Centre","ror":"https://ror.org/0436znn81","country_code":"GB","type":"facility","lineage":["https://openalex.org/I34931013","https://openalex.org/I4392738208"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Darren M. Ashcroft","raw_affiliation_strings":["Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester UK","NIHR Greater Manchester Patient Safety Translational Research Centre, Faculty of Biology, Medicine and Health University of Manchester  UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Pharmacoepidemiology and Drug Safety, Division of Pharmacy and Optometry, School of Health Sciences, Manchester Academic Health Science Centre University of Manchester UK","institution_ids":["https://openalex.org/I2799725268","https://openalex.org/I28407311"]},{"raw_affiliation_string":"NIHR Greater Manchester Patient Safety Translational Research Centre, Faculty of Biology, Medicine and Health University of Manchester  UK","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4392738208"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5049968381"],"corresponding_institution_ids":["https://openalex.org/I185163786","https://openalex.org/I2799725268","https://openalex.org/I28407311"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":{"value":4000,"currency":"USD","value_usd":4000},"fwci":1.5277,"has_fulltext":true,"cited_by_count":12,"citation_normalized_percentile":{"value":0.82331512,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"88","issue":"5","first_page":"2213","last_page":"2222"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.8109999895095825,"subfield":{"id":"https://openalex.org/subfields/3604","display_name":"Emergency Medical Services"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","score":0.8109999895095825,"subfield":{"id":"https://openalex.org/subfields/3604","display_name":"Emergency Medical Services"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.1534000039100647,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.014000000432133675,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":1.0},{"id":"https://openalex.org/keywords/pediatric-intensive-care","display_name":"pediatric intensive care","score":0.9369999766349792},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.6340000033378601},{"id":"https://openalex.org/keywords/preventability","display_name":"preventability","score":0.9760000109672546},{"id":"https://openalex.org/keywords/severity","display_name":"severity","score":0.6480000019073486},{"id":"https://openalex.org/keywords/causality-assessment","display_name":"causality assessment","score":0.6930000185966492},{"id":"https://openalex.org/keywords/picu-length-of-stay","display_name":"PICU length of stay","score":0.6759999990463257},{"id":"https://openalex.org/keywords/central-nervous-system-drugs","display_name":"central nervous system drugs","score":0.6700000166893005},{"id":"https://openalex.org/keywords/cardiovascular-drugs","display_name":"cardiovascular drugs","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4480000138282776},{"id":"https://openalex.org/keywords/harm-prevention","display_name":"harm prevention","score":0.3449999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9002498388290405},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.7294753789901733},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.6482069492340088},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.5546883940696716},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.5279822945594788},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5231243968009949},{"id":"https://openalex.org/C2987404301","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care","level":2,"score":0.4903576374053955},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4668496251106262},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4607132375240326},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4386090636253357},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.2760464549064636},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26920682191848755},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015278","descriptor_name":"Intensive Care Units, Pediatric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/bcp.15150","doi":"https://doi.org/10.1111/bcp.15150","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.15150","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15150","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:34878686","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34878686","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/ff538637-8ea5-4f2f-95d0-2ec19cc598a6","doi":null,"is_oa":true,"landing_page_url":"https://research.manchester.ac.uk/en/publications/ff538637-8ea5-4f2f-95d0-2ec19cc598a6","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Alghamdi, A A, Keers, R N, Sutherland, A, Hann, M, Gray, J, Mason, G, Isaac, R E & Ashcroft, D M 2022, 'Incidence and nature of adverse drug events in paediatric intensive care units: A prospective multicentre study', British Journal of Clinical Pharmacology, vol. 88, no. 5, pp. 2213-2222. https://doi.org/10.1111/bcp.15150","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1111/bcp.15150","doi":"https://doi.org/10.1111/bcp.15150","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bcp.15150","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.15150","source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200330587.pdf","grobid_xml":"https://content.openalex.org/works/W4200330587.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W40041486","https://openalex.org/W186640681","https://openalex.org/W570776158","https://openalex.org/W1879052186","https://openalex.org/W1917439754","https://openalex.org/W1970219260","https://openalex.org/W1981379351","https://openalex.org/W1995422727","https://openalex.org/W2011809814","https://openalex.org/W2034239455","https://openalex.org/W2038705819","https://openalex.org/W2055341118","https://openalex.org/W2071538556","https://openalex.org/W2090226269","https://openalex.org/W2113209364","https://openalex.org/W2113274285","https://openalex.org/W2131225010","https://openalex.org/W2135609841","https://openalex.org/W2140814138","https://openalex.org/W2156886529","https://openalex.org/W2160841074","https://openalex.org/W2161669645","https://openalex.org/W2162289225","https://openalex.org/W2164406831","https://openalex.org/W2166641093","https://openalex.org/W2310901737","https://openalex.org/W2317688282","https://openalex.org/W2400657289","https://openalex.org/W2887161102","https://openalex.org/W2913024107","https://openalex.org/W2964863519","https://openalex.org/W2968253755","https://openalex.org/W2988615777","https://openalex.org/W3020045697","https://openalex.org/W3141534542","https://openalex.org/W4212850438","https://openalex.org/W4229779919","https://openalex.org/W4240055551","https://openalex.org/W4252755710","https://openalex.org/W4294457161"],"related_works":["https://openalex.org/W3135577172","https://openalex.org/W2034239455","https://openalex.org/W2313385666","https://openalex.org/W2156886529","https://openalex.org/W3135877598","https://openalex.org/W2079215577","https://openalex.org/W416515542","https://openalex.org/W40041486","https://openalex.org/W2257968051","https://openalex.org/W2910428694"],"abstract_inverted_index":{"AIMS:":[0],"The":[1,107,128],"aim":[2],"of":[3,15,59,63,81,86,110,130,208,220,235,248],"this":[4],"study":[5,34],"was":[6,35,66],"to":[7,198,203,254],"assess":[8],"the":[9,136,159],"incidence,":[10],"nature,":[11],"preventability":[12,78],"and":[13,52,79,91,120,150,168,218,233],"severity":[14,80],"adverse":[16],"drug":[17],"events":[18],"(ADEs)":[19],"across":[20,37],"three":[21,38],"paediatric":[22],"intensive":[23],"care":[24],"units":[25],"(PICUs)":[26],"in":[27,54,99,185,215],"England.":[28],"METHODS:":[29],"A":[30,72,84],"prospective":[31],"observational":[32],"cohort":[33],"conducted":[36],"PICUs":[39,217],"over":[40],"a":[41,57,206,227,240],"three-month":[42],"period":[43],"during":[44],"2019.":[45],"Included":[46],"patients":[47,88,101,116,182,204],"were":[48,89,94,112,132,142,173,195],"aged":[49],"\u226418":[50],"years":[51],"stayed":[53,184],"PICU":[55,70,186,236],"for":[56,158,187,242],"minimum":[58],"24":[60],"hours.":[61],"Identification":[62],"suspected":[64],"ADEs":[65,93,111,131,141,212,250],"performed":[67],"by":[68,135],"trained":[69],"pharmacists.":[71],"multidisciplinary":[73],"expert":[74,137],"panel":[75,138],"assessed":[76],"causality,":[77],"events.":[82],"RESULTS:":[83],"total":[85],"302":[87],"included":[90],"62":[92],"confirmed":[95],"(definite/probable":[96],"causality).":[97],"One":[98],"six":[100],"experienced":[102],"one":[103],"or":[104],"more":[105,196],"ADEs.":[106,177],"estimated":[108],"incidence":[109],"20.5":[113],"per":[114,122],"100":[115],"(95%":[117,125],"CI":[118,126,193],"15.3-27.5)":[119],"16.7":[121],"1000":[123],"patient-days":[124],"9.3-29.9).":[127],"majority":[129],"judged":[133],"preventable":[134,249],"(36/62,":[139],"58.1%).":[140],"commonly":[143,174],"involved":[144],"with":[145,176,205],"medicines":[146],"prescribing":[147],"(29/62,":[148],"46.8%)":[149],"caused":[151],"temporary":[152],"patient":[153],"harm":[154],"(42/62,":[155],"67.7%).":[156],"Medications":[157],"central":[160],"nervous":[161],"system":[162,170],"(14/62,":[163],"22.6%),":[164],"infections":[165],"(13/62,":[166],"20.9%)":[167],"cardiovascular":[169],"(12/62,":[171],"19.4%)":[172],"implicated":[175],"Multivariable":[178],"analysis":[179],"revealed":[180],"that":[181],"who":[183],"\u22657":[188],"days":[189],"(OR":[190],"6.29,":[191],"95%":[192],"2.42-16.32)":[194],"likely":[197],"experience":[199],"an":[200],"ADE":[201,231],"compared":[202],"stay":[207],"1-6":[209],"days.":[210],"CONCLUSION:":[211],"are":[213],"common":[214],"English":[216],"most":[219],"them":[221],"may":[222],"be":[223],"preventable.":[224],"There":[225],"is":[226,251],"strong":[228],"association":[229],"between":[230],"occurrence":[232],"duration":[234],"stay,":[237],"which":[238],"represents":[239],"target":[241],"remedial":[243],"interventions.":[244],"Exploring":[245],"contributory":[246],"factors":[247],"now":[252],"necessary":[253],"inform":[255],"preventive":[256],"policies.":[257]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-12-31T00:00:00"}